CURIS, INC. Proceeds from Long-term Lines of Credit
CURIS, INC. (CRIS) reported Proceeds from Long-term Lines of Credit of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2019-03-26
- CURIS, INC. proceeds from long-term lines of credit for the quarter ending 2018-12-31 was $0.00.
- CURIS, INC. proceeds from long-term lines of credit for the quarter ending 2018-09-30 was $0.00.
- CURIS, INC. proceeds from long-term lines of credit for the quarter ending 2018-06-30 was $0.00.
- CURIS, INC. proceeds from long-term lines of credit for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- CURIS, INC. proceeds from long-term lines of credit for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- CURIS, INC. proceeds from long-term lines of credit for fiscal 2017 was $45.00M.
- CURIS, INC. proceeds from long-term lines of credit for fiscal 2016 was $0.00.
- CURIS, INC. proceeds from long-term lines of credit for fiscal 2015 was $0.00.
| Period end | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 6 month | Proceeds from Long-term Lines of Credit 9 month | Proceeds from Long-term Lines of Credit 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $0.00 derived: sum of 2 quarters · filed 2019-03-26 | $0.00 derived: sum of 3 quarters · filed 2019-03-26 | $0.00 10-K · filed 2019-03-26 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 derived: sum of 2 quarters · filed 2018-11-01 | $0.00 10-Q · filed 2018-11-01 | $0.00 derived: sum of 4 quarters · filed 2019-03-26 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $0.00 10-Q · filed 2018-08-02 | $0.00 derived: sum of 3 quarters · filed 2019-03-26 | $0.00 derived: sum of 4 quarters · filed 2019-03-26 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-03 | $0.00 derived: sum of 2 quarters · filed 2019-03-26 | $0.00 derived: sum of 3 quarters · filed 2019-03-26 | $0.00 derived: sum of 4 quarters · filed 2019-03-26 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $0.00 derived: sum of 2 quarters · filed 2019-03-26 | $0.00 derived: sum of 3 quarters · filed 2019-03-26 | $45.00M 10-K · filed 2019-03-26 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 derived: sum of 2 quarters · filed 2018-11-01 | $45.00M 10-Q · filed 2018-11-01 | $45.00M derived: sum of 4 quarters · filed 2018-11-01 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $45.00M 10-Q · filed 2018-08-02 | $45.00M derived: sum of 3 quarters · filed 2018-08-02 | $45.00M derived: sum of 4 quarters · filed 2018-08-02 |
| 2017-03-31 | $45.00M 10-Q · filed 2018-05-03 | $45.00M derived: sum of 2 quarters · filed 2018-05-03 | $45.00M derived: sum of 3 quarters · filed 2018-05-03 | $45.00M derived: sum of 4 quarters · filed 2018-05-03 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $0.00 derived: sum of 2 quarters · filed 2018-03-08 | $0.00 derived: sum of 3 quarters · filed 2018-03-08 | $0.00 10-K · filed 2018-03-08 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |